{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T11:50:32Z","timestamp":1696506632149},"reference-count":43,"publisher":"American Association for Cancer Research (AACR)","issue":"9","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>For clinically relevant studies on melanoma progression and invasiveness, in vivo experimental systems with a human cellular microenvironment would be advantageous. We have compared tumor formation from a human cutaneous malignant melanoma cell line (BL), after injection as conventional xenografts in the mouse, or when injected into a predominantly species-specific environment of human embryonic stem cell\u2013derived teratoma induced in the mouse (the hEST model). The resulting melanoma histology was generally analogous, both systems showing delimited densely packed areas with pleomorphic cells of malignant appearance. A specificity of the integration process into the human embryonic teratoma tissues was indicated by the melanoma exclusively being found in areas compatible with condensed mesenchyme, similar to neural crest development. Here, also enhanced neovascularization was seen within the human mesenchymal tissues facing the BL melanoma growth. Furthermore, in the hEST model an additional melanoma cell phenotype occurred, located at the border of, or infiltrating into, the surrounding human loose mesenchymal fibrous stroma. This BL population had a desmoplastic spindle-like appearance, with markers indicative of dedifferentiation and migration. The appearance of this apparently more aggressive phenotype, as well as the induction of human angiogenesis, shows specific interactions with the human embryonic microenvironment in the hEST model. In conclusion, these data provide exciting options for using the hEST model in molecular in vivo studies on differentiation, invasiveness, and malignancy of human melanoma, while analyzing species-specific reactions in vivo. [Cancer Res 2009;69(9):3746\u201354]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-3746","type":"journal-article","created":{"date-parts":[[2009,4,22]],"date-time":"2009-04-22T03:00:39Z","timestamp":1240369239000},"page":"3746-3754","update-policy":"http:\/\/dx.doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Species-Specific <i>In vivo<\/i> Engraftment of the Human BL Melanoma Cell Line Results in an Invasive Dedifferentiated Phenotype Not Present in Xenografts"],"prefix":"10.1158","volume":"69","author":[{"given":"Jessica","family":"Cedervall","sequence":"first","affiliation":[{"name":"1Woman and Child Health, Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Jamil","sequence":"additional","affiliation":[{"name":"1Woman and Child Health, Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Prasmickaite","sequence":"additional","affiliation":[{"name":"4Department of Tumor Biology and the Cancer Stem Cell Innovation Center, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YenFu","family":"Cheng","sequence":"additional","affiliation":[{"name":"2Clinical Neuroscience, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malihe","family":"Eskandarpour","sequence":"additional","affiliation":[{"name":"3Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska, Karolinska University Hospital Solna, Stockholm, Sweden;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Hansson","sequence":"additional","affiliation":[{"name":"3Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska, Karolinska University Hospital Solna, Stockholm, Sweden;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunhild M.","family":"M\u00e6landsmo","sequence":"additional","affiliation":[{"name":"4Department of Tumor Biology and the Cancer Stem Cell Innovation Center, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrik","family":"Ringborg","sequence":"additional","affiliation":[{"name":"3Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska, Karolinska University Hospital Solna, Stockholm, Sweden;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miklos","family":"Gulyas","sequence":"additional","affiliation":[{"name":"6Department of Pathology and Cytology, Central Hospital, Ga\u0308vle, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He Suo","family":"Zhen","sequence":"additional","affiliation":[{"name":"5Department of Pathology, Norwegian Radium Hospital, Rikshospitalet University Hospital, Faculty Division, University of Oslo, Oslo, Norway; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Kanter","sequence":"additional","affiliation":[{"name":"3Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska, Karolinska University Hospital Solna, Stockholm, Sweden;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"A\u0308hrlund-Richter","sequence":"additional","affiliation":[{"name":"1Woman and Child Health, Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2009,4,30]]},"reference":[{"key":"2022061701490399700_B1","doi-asserted-by":"crossref","unstructured":"Levenberg S, Huang NF, Lavik E, Rogers AB, Itskovitz-Eldor J, Langer R. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. PNAS\u20082003; 100: 12741\u20136.","DOI":"10.1073\/pnas.1735463100"},{"key":"2022061701490399700_B2","doi-asserted-by":"crossref","unstructured":"Smalley KS, Lioni M, Noma K, Haass NK, Herlyn M. In vitro three-dimentional tumor microenvironment models for anticancer drug discovery. Expert Opin Drug Discov\u20082008; 3: 1\u201320.","DOI":"10.1517\/17460441.3.1.1"},{"key":"2022061701490399700_B3","doi-asserted-by":"crossref","unstructured":"Seftor EA, Meltzer PS, Kirschmann DA, Margaryan NV, Seftor RE, Hendrix MJ. The epigenetic reprogramming of poorly aggressive melanoma cells by a metastatic microenvironment. J Cell Mol Med\u20082006; 10: 174\u201396.","DOI":"10.1111\/j.1582-4934.2006.tb00299.x"},{"key":"2022061701490399700_B4","doi-asserted-by":"crossref","unstructured":"Kuperwasser C, Chavarria T, Wu M, et al. Reconstruction of functionally normal and malignant human breast tissues in mice. PNAS\u20082004; 101: 4966\u201371.","DOI":"10.1073\/pnas.0401064101"},{"key":"2022061701490399700_B5","doi-asserted-by":"crossref","unstructured":"Chen J, Blackwell TW, Fermin D, et al. Evolutionary-conserved gene expression response profiles across mammalian tissues. OMICS\u20082007; 11: 96\u2013115.","DOI":"10.1089\/omi.2006.0007"},{"key":"2022061701490399700_B6","doi-asserted-by":"crossref","unstructured":"Tzukerman M, Rosenberg T, Ravel Y, Reiter I, Coleman R, Skorecki K. An experimental platform for studying growth and invasiveness of tumor cells within teratomas derived from human embryonic stem cells. PNAS\u20082003; 100: 13507\u201312.","DOI":"10.1073\/pnas.2235551100"},{"key":"2022061701490399700_B7","doi-asserted-by":"crossref","unstructured":"Tzukerman M, Rosenberg T, Reiter I, et al. The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts. Cancer Res\u20082006; 66: 3792\u201381.","DOI":"10.1158\/0008-5472.CAN-05-3467"},{"key":"2022061701490399700_B8","doi-asserted-by":"crossref","unstructured":"Hovatta O, Mikkola M, Gertow K, et al. A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum Reprod\u20082003; 18: 1404\u20139.","DOI":"10.1093\/humrep\/deg290"},{"key":"2022061701490399700_B9","doi-asserted-by":"crossref","unstructured":"Inzunza J, Gertow K, Stro\u0308mberg AM, et al. Derivation of human embryonic stem cell lines in serum-free medium using postnatal human fibroblasts as feeder cells. Stem Cells\u20082005; 23: 544\u20139.","DOI":"10.1634\/stemcells.2004-0201"},{"key":"2022061701490399700_B10","doi-asserted-by":"crossref","unstructured":"Gertow K, Przyborski S, Loring J, et al. Isolation of HESC-derived teratomas for the assessment of pluripotency. In: Current Protocols in Stem Cell Biology. Chapt 1B:4, 2007. p.1\u201324.","DOI":"10.1002\/9780470151808.sc01b04s3"},{"key":"2022061701490399700_B11","doi-asserted-by":"crossref","unstructured":"Gertow K, Wolbank S, Rozell B, et al. Organized development from human embryonic stem cells after injection into immunodeficient mice. Stem Cells Dev\u20082004; 13: 421\u20135.","DOI":"10.1089\/scd.2004.13.421"},{"key":"2022061701490399700_B12","unstructured":"Damjanov I, A\u0308hrlund-Richter L. Characterization of hESC-derived teratomas. In Human Stem Cell Manual: A Laboratory Guide, by Loring JF, Schwartz PH, and Wesselschmidt R. Elsevier Press. 2007."},{"key":"2022061701490399700_B13","doi-asserted-by":"crossref","unstructured":"Gertow K, Cedervall J, Unger C, et al. Trisomy 12 in HESC leads to no selective in vivo growth advantage in teratomas, but induces an increased abundance of renal development. J Cell Biochem\u20082007; 100: 1518\u201325.","DOI":"10.1002\/jcb.21144"},{"key":"2022061701490399700_B14","doi-asserted-by":"crossref","unstructured":"Imreh M, Gertow K, Cedervall J, et al. In vitro culture conditions favoring selection of chromosomal abnormalities in human ES cells. J Cell Biochem\u20082006; 99: 508\u201316.","DOI":"10.1002\/jcb.20897"},{"key":"2022061701490399700_B15","doi-asserted-by":"crossref","unstructured":"Gerecht-Nir S, Osenberg S, Nevo O, Ziskind A, Coleman R, Itskovitz-Eldor J. Vascular development in early human embryos and in teratomas derived from human embryonic stem cells. Biol Reprod\u20082004; 71: 2029\u201336.","DOI":"10.1095\/biolreprod.104.031930"},{"key":"2022061701490399700_B16","unstructured":"Salazar-Onfray F, Nakazawa T, Chhajlani V, et al. Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cells. Cancer Res\u20081997; 57: 4348\u201355."},{"key":"2022061701490399700_B17","doi-asserted-by":"crossref","unstructured":"Salazar-Onfray F, Lopez M, Lundqvist A, et al. Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker. Br J Cancer\u20082002; 87: 414\u201322.","DOI":"10.1038\/sj.bjc.6600441"},{"key":"2022061701490399700_B18","doi-asserted-by":"crossref","unstructured":"Topczewska JM, Postovit LM, Margaryan NV, et al. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med\u20082006; 12: 925\u201332.","DOI":"10.1038\/nm1448"},{"key":"2022061701490399700_B19","doi-asserted-by":"crossref","unstructured":"Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol\u20082004; 51: 1\u201328.","DOI":"10.1016\/j.critrevonc.2004.04.007"},{"key":"2022061701490399700_B20","doi-asserted-by":"crossref","unstructured":"Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Vasculogenic mimicry and tumor-cell plasticity: lessons from melanoma. Nat Rev Cancer\u20082003; 3: 411\u201321.","DOI":"10.1038\/nrc1092"},{"key":"2022061701490399700_B21","doi-asserted-by":"crossref","unstructured":"Lee JT, Herlyn M. Microenvironmental influences in melanoma progression. J Cell Biochem\u20082007; 101: 862\u201372.","DOI":"10.1002\/jcb.21204"},{"key":"2022061701490399700_B22","doi-asserted-by":"crossref","unstructured":"Kulesa PM, Kasemeier-Kulesa JC, Teddy JM, et al. Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. PNAS\u20082006; 103: 3752\u20137.","DOI":"10.1073\/pnas.0506977103"},{"key":"2022061701490399700_B23","unstructured":"Hendrix MJ, Seftor RE, Seftor EA, et al. Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination. Cancer Res\u20082002; 62: 665\u20138."},{"key":"2022061701490399700_B24","doi-asserted-by":"crossref","unstructured":"Lee LM, Seftor EA, Bonde G, Cornell RA, Hendrix MJ. Dev Dyn\u20082005; 233: 1560\u201370.","DOI":"10.1002\/dvdy.20471"},{"key":"2022061701490399700_B25","doi-asserted-by":"crossref","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science\u20081998; 282: 1145\u20137.","DOI":"10.1126\/science.282.5391.1145"},{"key":"2022061701490399700_B26","doi-asserted-by":"crossref","unstructured":"Imreh MP, Wolbank S, Unger C, et al. Culture and expansion of the human embryonic stem cell line HS181, evaluated in a double color system. Stem Cells Dev\u20082004; 13: 337\u201343.","DOI":"10.1089\/scd.2004.13.337"},{"key":"2022061701490399700_B27","doi-asserted-by":"crossref","unstructured":"Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol\u20081999; 155: 739\u201352.","DOI":"10.1016\/S0002-9440(10)65173-5"},{"key":"2022061701490399700_B28","doi-asserted-by":"crossref","unstructured":"Maniotis AJ, Chen X, Garcia C, et al. Control of melanoma morphogenesis, endothelial survival, and perfusion by extracellular matrix. Lab Invest\u20082002; 82: 1031\u201343.","DOI":"10.1097\/01.LAB.0000024362.12721.67"},{"key":"2022061701490399700_B29","unstructured":"Ruf W, Seftor EA, Petrovan RJ, et al. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry. Cancer Res\u20082003; 63: 5381\u20139."},{"key":"2022061701490399700_B30","doi-asserted-by":"crossref","unstructured":"Garrett SC, Varney KM, Weber DJ, Bresnick AR. S100A4, a mediator of metastasis. J Biol Chem\u20082006; 281: 677\u201380.","DOI":"10.1074\/jbc.R500017200"},{"key":"2022061701490399700_B31","doi-asserted-by":"crossref","unstructured":"Flatmark K, Maelandsmo GM, Mikalsen SO, et al. Immunofluorometric assay for the metastasis-related protein S100A4: release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum. Tumour Biol\u20082004; 25: 31\u201340.","DOI":"10.1159\/000077721"},{"key":"2022061701490399700_B32","doi-asserted-by":"crossref","unstructured":"Brychtova S, Fiuraskova M, Hlobilkova' A, Brychta T, Hirnak J. Nestin expression in cutaneous melanomas and melanocytic nevi. J Cutan Pathol\u20082007; 34: 370\u20135.","DOI":"10.1111\/j.1600-0560.2006.00627.x"},{"key":"2022061701490399700_B33","doi-asserted-by":"crossref","unstructured":"Ehrmann J, Kola\u0301r Z, Mokry J. Nestin as a diagnostic and prognostic marker: immunohistochemical analysis of its expression in different tumors. J Clin Pathol\u20082005; 58: 222\u20133.","DOI":"10.1136\/jcp.2004.021238"},{"key":"2022061701490399700_B34","doi-asserted-by":"crossref","unstructured":"Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech\u20082003; 60: 540\u201351.","DOI":"10.1002\/jemt.10296"},{"key":"2022061701490399700_B35","doi-asserted-by":"crossref","unstructured":"Mueller A, Scha\u0308fer BW, Ferrari S. The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J Biol Chem\u20082005; 280: 29186\u201393.","DOI":"10.1074\/jbc.M505000200"},{"key":"2022061701490399700_B36","doi-asserted-by":"crossref","unstructured":"Kriajevska M, Fischer-Larsen M, Moertz E, et al. Liprin \u03b2 1, a member of the family of LAR transmembrane tyrosine phosphatase-interacting proteins, is a new target for the metastasis-associated protein S100A4 (Mts1). J Biol Chem\u20082003; 277: 5229\u201335.","DOI":"10.1074\/jbc.M110976200"},{"key":"2022061701490399700_B37","doi-asserted-by":"crossref","unstructured":"Postovit LM, Margaryan NV, Seftor EA, et al. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. PNAS\u20082008; 105: 4329\u201334.","DOI":"10.1073\/pnas.0800467105"},{"key":"2022061701490399700_B38","doi-asserted-by":"crossref","unstructured":"Drukker M, Katz G, Urbach A, et al. Characterization of the expression of MHC proteins in human embryonic stem cells. PNAS\u20082002; 99: 9864\u20139.","DOI":"10.1073\/pnas.142298299"},{"key":"2022061701490399700_B39","doi-asserted-by":"crossref","unstructured":"Chen YT, Dejosez M, Zwaka TP, Behringer RR. H1 and H9 human embryonic stem cell lines are heterozygous for the ABO locus. Stem Cells Dev. Epub ahead of print 2008 Jun 18.","DOI":"10.1089\/scd.2007.0226"},{"key":"2022061701490399700_B40","doi-asserted-by":"crossref","unstructured":"Bradley JA, Bolton EM, Pedersen RA. Stem cell medicine encounters the immune system. Nat Rev Immunol\u20082002; 2: 859\u201371.","DOI":"10.1038\/nri934"},{"key":"2022061701490399700_B41","doi-asserted-by":"crossref","unstructured":"Mosier DE, Stell KL, Gulizia RJ, Torbett BE, Gilmore GL. Homozygous scid\/scid;beige\/beige mice have low levels of spontaneous or neonatal T cell-induced B cell generation. J Exp Med\u20081993; 177: 191\u20134.","DOI":"10.1084\/jem.177.1.191"},{"key":"2022061701490399700_B42","doi-asserted-by":"crossref","unstructured":"Eskandarpour M, Kiaii S, Zhu C, Castro J, Sakko AJ, Hansson J. Suppression of oncogenic NRAS by RNA interference induces apoptosis of human melanoma cells. Int J Cancer\u20082005; 115: 65\u201373.","DOI":"10.1002\/ijc.20873"},{"key":"2022061701490399700_B43","doi-asserted-by":"crossref","unstructured":"Eskandarpour M, Huang F, Reeves KA, Clark E, Hansson J. Oncogenic NRAS has multiple effects on the malignant phenotype of human melanoma cells cultured in vitro. Int J Cancer\u20082009; 124: 16\u201326.","DOI":"10.1002\/ijc.23876"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/9\/3746\/2624020\/3746.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/9\/3746\/2624020\/3746.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T09:21:20Z","timestamp":1655457680000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/9\/3746\/553345\/Species-Specific-In-vivo-Engraftment-of-the-Human"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,30]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2009,4,30]]},"published-print":{"date-parts":[[2009,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-3746","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,30]]}}}